Genmab A/S (FRA:GE9)

Genmab Revenue

Genmab had revenue of $5.86B USD in the quarter ending June 30, 2025, with 40.50% growth. This brings the company's revenue in the last twelve months to $22.16B, up 24.58% year-over-year. In the year 2024, Genmab had annual revenue of $21.53B with 30.67% growth.

• Revenue (ttm): $22.16B
• Revenue Growth: +24.58%
• P/S Ratio: 5.14
• Revenue / Employee: $8.26M
• Employees: 2,682
• Market Cap: 16.85B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	21.53B	5.05B	30.67%
Dec 31, 2023	16.47B	1.97B	13.57%
Dec 31, 2022	14.51B	6.09B	72.33%
Dec 31, 2021	8.42B	-1.69B	-16.75%
Dec 31, 2020	10.11B	4.75B	88.43%
Dec 31, 2019	5.37B	2.34B	77.39%
Dec 31, 2018	3.03B	659.56M	27.88%
Dec 31, 2017	2.37B	-1.34B	-36.18%
Dec 31, 2016	3.71B	1.44B	63.31%
Dec 31, 2015	2.27B	-	-